This proposal requests continuing support for the General Clinical Research Center of Duke University Medical Center. This center, known at Duke as the Rankin Clinical Research Unit (CRU), consists of a hospital inpatient ward, an outpatient clinic, a metabolic kitchen, a sample- processing core laboratory, a computerized database management and analysis (CDMAS) system, and other ancillary services. It provides an atmosphere for controlled observation and timely collection of patient samples including blood, urine, bacteriology cultures, etc. A new initiative described in this application is the creation of two new Core Laboratory facilities (called the Cellular and Vector-Production Core Laboratories) which will facilitate transfer of new cellular and genetic technologies to clinical trials. This initiative will allow the Rankin CRU to remain at the forefront of clinical research at Duke, and indeed this initiative will speed the development of clinical protocols using new forms of therapy. Use of any of the components of the center by a physician-investigator requires approval of the Clinical Research Unit (CRU) Scientific Advisory Committee and approval of the Institutional Review Board for Clinical Investigations. All Duke University Medical Center faculty with hospital admitting privileges are eligible to submit protocols to the Scientific Advisory Committee. Current protocols have principal investigators from Medicine, Obstetrics and Gynecology, Pediatrics, Psychiatry, and Surgery. There is substantial collaboration among clinician-investigators in the clinical departments and between CRU investigators in clinical departments and complementary basic science departments. The CRU also is the site for training medical students, house officers, and post doctoral fellows in the latest research methodology. Included in this application is a description of accomplishments since the previous site visit, a complete center bibliography, a description of the program conducted by the center, and future plans.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000030-37
Application #
2546515
Study Section
General Clinical Research Centers Committee (CLR)
Project Start
1975-10-01
Project End
1998-11-30
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
37
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417
Ahmed, Zuhayer; Prasad, Indrajit; Rahman, Hafizur et al. (2016) A Male with Extreme Subcutaneous Insulin Resistance: A Case Report. Rom J Diabetes Nutr Metab Dis 23:209-213
Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17
Adams, Rebecca N; Mosher, Catherine E; Blair, Cindy K et al. (2015) Cancer survivors' uptake and adherence in diet and exercise intervention trials: an integrative data analysis. Cancer 121:77-83
Azrad, M; Vollmer, R T; Madden, J et al. (2015) Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial. Biotech Histochem 90:184-9

Showing the most recent 10 out of 128 publications